CannAlliance accelerates the development and adoption of novel cannabis-based products and therapies by providing resources a ... nd expertise that facilitate clinical research in Israel by BOL Pharma, Pharmaseed, Cato Research, Bioforum the Data Masters and IMP Clinical Supply Services. A friendly regulatory environment combined with the country’s FDA approved medical research ecosystem has enabled academic and commercial entities to lead the industry in phytocannabinoid clinical research. CannAlliance brings together scientists, entrepreneurs, academic institutions and industry partners to drive the development of evidence based phytocannabinoid therapeutics. The CannAlliance model is designed to enable researchers to plug into the platform based on their needs and objectives. The platform is a flexible, all-inclusive source for launching and conducting clinical research from preclinical to FDA preparation. read more